The Longevity Therapeutics conference enters its second year, opening its doors on January 28th for a three-day event focused on aging research. If you are interested in the actual science happening in the field with no snake oil in sight, then this is the West Coast conference to attend.
With over 80 speakers, including researchers, biotech startup CEOs, investors, and pharmaceutical experts, it promises to be a very interesting event. Companies and institutions such as AgeX Therapeutics, Juvena therapeutics, Buck Institute for Research on Aging, ResTORbio, NIH, and Unity Biotechnologies will be presenting at the event.
Some of the highlights for the conference will be:
- Unity Biotechnologies will be announcing its first-in-human trial results and its next steps for the future.
- Juvena Therapeutics will be talking about how the use of quantitative proteomics and AI can accelerate preclinical development of rejuvenation therapies.
- The Buck Institute for Research on Aging will be discussing the evidence for the role of cellular senescence in Alzheimer’s disease and the potential use of senolytics as therapeutics in its later stages.
Lifespan.io is an official media partner of the event, and our reporting team will be on site to bring you the latest industry news and interviews with the researchers, so stay tuned in the coming weeks as we publish articles from this event.
There are only three days left to register for what is sure to be an amazing conference packed with some of the leading minds in the field of rejuvenation biotechnology.